Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlæge Anne-Mette Fogemann ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.5% 0.5%   Bankruptcy risk   10.1% 11.5% 4.8% 3.9% 3.7% 3.9% 10.0% 10.0%   Credit score (0-100)   26 22 45 49 52 49 25 25   Credit rating   BB BB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   -0.0 -0.0 -0.0 -0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,548 2,124 2,603 2,933 3,492 3,676 0.0 0.0   EBITDA   -37.9 229 390 698 682 484 0.0 0.0   EBIT   -335 -139 15.8 236 113 55.5 0.0 0.0   Pre-tax profit (PTP)   -444.6 -293.9 -159.4 69.5 -78.3 -117.8 0.0 0.0   Net earnings   -346.6 -229.5 -124.3 61.5 -55.8 -87.1 0.0 0.0   Pre-tax profit without non-rec. items   -445 -294 -159 69.5 -78.3 -118 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   1,501 1,231 972 1,835 1,517 1,237 0.0 0.0   Shareholders equity total   -703 -932 -1,057 -995 -1,051 -1,134 -1,184 -1,184   Interest-bearing liabilities   1,132 982 3,854 4,696 4,825 4,975 2,010 2,010   Balance sheet total (assets)   3,288 3,169 3,423 4,186 4,383 4,463 826 826   Net Debt   1,125 962 3,476 4,369 3,954 3,515 2,010 2,010     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,548 2,124 2,603 2,933 3,492 3,676 0.0 0.0   Gross profit growth   6.0% 37.1% 22.6% 12.7% 19.1% 5.3% -100.0% 0.0%   Employees   1 3 4 5 6 7 0 0   Employee growth %   0.0% 200.0% 33.3% 25.0% 20.0% 16.7% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,288 3,169 3,423 4,186 4,383 4,463 826 826   Balance sheet change%   41.5% -3.6% 8.0% 22.3% 4.7% 1.8% -81.5% 0.0%   Added value   -37.9 228.9 389.6 698.1 575.6 484.2 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   318 -713 -708 325 -962 -784 -1,237 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   -3.0 -4.0 1.0 2.0 3.0 4.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   -21.7% -6.5% 0.6% 8.0% 3.2% 1.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   -9.9% -3.4% 0.4% 4.9% 2.1% 1.4% 0.0% 0.0%   ROI %   -56.6% -12.9% 0.6% 5.4% 1.6% 0.8% 0.0% 0.0%   ROE %   -12.4% -7.1% -3.8% 1.6% -1.3% -2.0% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   -17.6% -22.7% -23.6% -19.2% -19.3% -20.3% -58.9% -58.9%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -2,967.2% 420.1% 892.1% 625.8% 579.5% 725.9% 0.0% 0.0%   Gearing %   -161.1% -105.3% -364.7% -471.9% -459.1% -438.8% -169.8% -169.8%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   19.6% 14.7% 7.2% 3.9% 4.0% 4.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.1 0.2 0.3 0.2 5.4 5.9 0.0 0.0   Current Ratio   0.1 0.2 0.3 0.2 5.4 5.9 0.0 0.0   Cash and cash equivalent   7.0 19.9 378.2 327.6 871.6 1,460.1 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -3,504.8 -3,347.2 -3,094.1 -3,840.9 1,485.6 1,871.8 -1,004.8 -1,004.8   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   -38 76 97 140 96 69 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   -38 76 97 140 114 69 0 0   EBIT / employee   -335 -46 4 47 19 8 0 0   Net earnings / employee   -347 -76 -31 12 -9 -12 0 0